Wednesday, July 8, 2026

Drug profile · INN

amiodarone hydrochloride

amiodarone hydrochloride (AMIODARONE HYDROCHLORIDE) is a herg blocker. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — amiodarone hydrochloride
US status
approved
Class
Route
INJECTION
Patents
0
Programs
1
Data quality
0.89

Quick answer

amiodarone hydrochloride (AMIODARONE HYDROCHLORIDE) is a herg blocker. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN amiodarone hydrochloride
Brand AMIODARONE HYDROCHLORIDE
Mechanism HERG blocker
Target Voltage-gated inwardly rectifying potassium channel KCNH2
Route INJECTION
Formulation INJECTABLE

Mechanism of action

HERG blocker

Primary target: Voltage-gated inwardly rectifying potassium channel KCNH2

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Amiodarone hydrochloride 200 mg tablets Approved · George Institute for · Persistent atrial fibrillation

Related & competitor drugs

  1. dofetilide Cardiovascular system (C01)
  2. ibutilide fumarate HERG blocker
  3. vernakalant hydrochloride Cardiovascular system (C01)

Frequently asked questions

What is amiodarone hydrochloride?

amiodarone hydrochloride (AMIODARONE HYDROCHLORIDE) is a herg blocker. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for amiodarone hydrochloride?

AMIODARONE HYDROCHLORIDE is a marketed brand name for amiodarone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of amiodarone hydrochloride?

amiodarone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.